Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Many researchers notice nothing definitive during the first two weeks
The FDA has restored GHK-Cu for non-injectable use to Category 1 of its 503A bulk drug substances list, reversing an April 22, 2026 removal that compounding pharmacies had been scrambling to interpret for the better part of a month
This is particularly important for anyone experiencing thinning hair or slow hair growth, as it helps to revitalise the scalp and promote hair rejuvenation
Reported observations include: Temporary injection site irritation Mild redness Temporary swelling Local discomfort Mild headache Researchers continue examining long-term biological responses across different laboratory models
US$ 29.07
US$ 26.48
US$ 28.78
